Oxidative stress-inducible lentiviral vectors for gene therapy

Gene Therapy

Volumn 15, Issue 18, 2008, Pages 1271-1279

  Hurttila, H ^a   Koponen, J K ^a   Kansanen, E ^a   Jyrkkanen H K ^a   Kivela A ^a   Kylatie R ^a   Yla Herttuala S ^a,b   Levonen, A L ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; LUCIFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; OXIDATIVE STRESS; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL LINE; CLONING, MOLECULAR; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GLUTAMATE-CYSTEINE LIGASE; HEME OXYGENASE-1; HIV-1; HUMANS; LUCIFERASES; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; RESPONSE ELEMENTS; TRANSDUCTION, GENETIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 51049094472     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.75     Document Type: Article

References (46)

1. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular inBury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003; 108: 1912-1916.
2. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000; 109: 315-323.
3. Levonen AL, Vähäkangas E, Koponen JK, Yla-Herttuala S. Antioxidant gene therapy for cardiovascular disease: Current status and future perspectives. Circulation (in press).
4. Stocker R, Perrella MA. Heme oxygenase-1: A novel drug target for atherosclerotic diseases? Circulation 2006; 114: 2178-2189.
5. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
6. Alam J, Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 2003; 9 2499-2511.
7. Scares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 2004; 172: 3553-3563.
8. Seldon MP, Silva G, Pejanovic N, Larsen R, Gregoire IP, Filipe J et al. Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-(kappa)B Re1A phosphorylation at serine 276. J Immunol 2007; 179: 7840-7851.
9. Berens C, Hillen W. Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. Eur J Biochem 2003; 270: 3109-3121.
10. Pachori AS, Melo LG, Hart ML, Noiseux N, Zhang L, Morello F et al. Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci USA 2004; 101: 12282-12287.
11. Tang YL, Qian K, Zhang YC, Shen L, Phillips MI. A vigilant hypoxia-regulated heme. oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther 2005; 10: 251-263.
12. Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003; 43: 233-260.
13. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991; 266: 11632-11639.
14. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997; 236: 313-322.
15. Zhang DD. Mechanistic studies of the Nrf2-Keapl signaling pathway. Drug Metab Rev 2006; 38: 769-789.
16. Kannan S, Jaiswal AK. Low and high dose UVB regulation of transcription factor NF-E2-related factor 2. Cancer Res 2006; 66: 8421-8429.
17. Levonen AL, Landar A, Ramachandran A, Ceaser EK, Dickinson DA, Zanoni G et al. Cellular mechanisms of redox cell signalling: Role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J 2004; 378: 373-382.
18. Mulcahy RT, Wartman MA, Bailey HH, Gipp JJ. Constitutive and beta-naphthoflavone-induced expression of the human gammaglutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem 1997; 272: 7445-7454.
19. Wild AC, Moinova HR, Mulcahy RT. Regulation of gammaglutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 1999; 274: 33627-33636.
20. Inamdar NM, Ahn YI, Alam J. The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem Biophys Res Commun 1996; 221: 570-576.
21. Li Y, Jaiswal AK. Regulation of human NAD(P)H:qUinone oxidureductase gene. Role of API binding site contained within human antioxidant response element. J Biol Chem 1992; 267: 15097-15104.
22. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K. 15-Deoxy-delta 12, 14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 2002; 277 10459-10466.
23. Taba Y, Sasaguri T, Miyagi M, Abumiya T, Miwa Y, Ikeda T et al. Fluid shear stress induces lipocalin-type prostaglandin D2 synthase expression in vascular endothelial cells. Circ Res 2000; 86: 967-973.
24. Hosoya T, Maruyama A, Kang MI, Kawatani Y, Shibata T, Uchida K et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 2005; 280: 27244-27250.
25. Dulak J, Zagorska A, Wegiel B, Loboda A, Jozkowicz A. New strategies for cardiovascular gene therapy: Regulatable preemptive expression of pro-angiogenic and antioxidant genes. Cell Biochem Biophys 2006; 44: 31-42.
26. Stocker R, Keaney Jr JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-1478.
27. Liu X, Pachori AS, Ward CA, Davis JP, Gnecchi M, Kong D et al. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J 2006; 20: 207-216.
28. Liu X, Simpson JA, Brunt KR, Ward CA, Hall SR, Kinobe RT et al. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 y after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2007; 293: H48-H59.
29. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 2003; 278: 703-711.
30. Chen XL, Dodd G, Thomas S, Zhang X, Wasserman MA, Rovin BH et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 2006; 290: H1862-H1870.
31. Levonen AL, Inkala M, Heikura T, Jauhiainen S, Jyrkkanen HK, Kansanen E et al. Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo. Arterioscler Thromb Vasc Biol 2007; 27: 741-747.
32. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086-1095.
33. Bea F, Hudson FN, Chait A, Kavanagh TJ, Rosenfeld ME. Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements. Circ Res 2003; 92: 386-393.
34. Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S et al. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 2006; 20: 2624-2626.
35. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47: 89-116.
36. Erickson AM, Nevarea Z, Gipp JJ, Mulcahy RT. Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence. J Biol Chem 2002; 277: 30730-30737.
37. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M et al. Oxygen sensing by primary cardiac fibroblasts: A key role of p21(Waf1/Cip1/Sdi1). Circ Res 2003; 92: 264-271.
38. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci USA 2002; 99: 9480-9485.
39. Cernuda-Morollon E, Pineda-Molina E, Canada FJ, Perez-Sala D. 15-Deoxy-delta 12, 14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J Biol Chem 2001; 276: 35530-35536.
40. Alam J, Den Z. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem 1992; 267: 21894-21900.
41. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 1989; 86: 99-103.
42. Makinen PI, Koponen JK, Karkkainen AM, Malm TM, Pulkkinen KH, Koistinaho J et al. Stable RNA interference: Comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med 2006; 8: 433-441.
43. Koponen JK, Kekarainen T, Heinonen SE, Laitinen A, Nystedt J, Laine J et al. Umbilical cord blood-derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model. Mol Ther 2007; 15: 2172-2177.
44. Follenzi A, Naldini L. HIV-based vectors. Preparation and use. Methods Mol Med 2002; 69: 259-274.
45. Levonen AL, Dickinson DA, Moellering DR, Mulcahy RT, Forman HJ, Darley-Usmar VM. Biphasic effects of 15-deoxydelta(12, 14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. Arterioscler Thromb Vasc Biol 2001; 21: 1846-1851.
46. Rosenthal N. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol 1987; 152: 704-720.